David N Gershfield, MD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gershfield’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A74994 · Current
Licensed to practise in California · since 2001 · expires 2027-03-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$143,549
Medicare paid this office $143,549 for 379 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 232 | $74,722 | $166 |
| New patient visit (60+ min) | 148 | $27,851 | $188 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 217 | $6,197 | $15 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 116 | $5,233 | $30 |
| Muscle electrical test | 35 | $4,645 | $95 |
See all 7 services
| Long return visit (40+ min) | 232 | $74,722 | $166 |
| New patient visit (60+ min) | 148 | $27,851 | $188 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 217 | $6,197 | $15 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 116 | $5,233 | $30 |
| Muscle electrical test | 35 | $4,645 | $95 |
| Return visit (30+ min) | 26 | $3,479 | $112 |
| Nerve test | 16 | $1,982 | $124 |
Who their Medicare patients are
379 Original Medicare patients in 2024. Average age 78 · Women 49% · Also on Medicaid 6% · Health risk score 0.98. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 62% · Coronary heart disease 23% · Depression 21% · Cancer 19% · Diabetes 17% · Chronic kidney disease 17% · Atrial fibrillation 16% · Dementia 16% · Stroke 10% · Heart failure 9% · COPD 6%.
The office billed $485,500, Medicare allowed $188,879 and paid $143,549; for 3,860 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 379 | 3,860 | 78 | 0.98 | $485,500 | $143,549 |
| 2023 | 380 | 3,860 | 78 | 1.00 | $414,986 | $127,553 |
| 2022 | 363 | 2,763 | 78 | 1.03 | $344,960 | $107,560 |
| 2021 | 402 | 1,195 | 77 | 0.98 | $327,031 | $106,060 |
| 2020 | 331 | 1,041 | 77 | 1.08 | $280,845 | $85,868 |
| 2019 | 344 | 892 | 76 | 1.07 | $303,565 | $88,334 |
| 2018 | 304 | 1,953 | 77 | 1.07 | $254,826 | $76,257 |
| 2017 | 276 | 1,166 | 76 | 1.00 | $236,163 | $70,413 |
| 2016 | 314 | 1,561 | 76 | 1.16 | $237,239 | $70,033 |
| 2015 | 370 | 995 | 76 | 1.10 | $281,983 | $87,990 |
| 2014 | 386 | 729 | 77 | 1.00 | $287,644 | $85,733 |
| 2013 | 333 | 601 | 76 | 1.10 | $236,697 | $71,193 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 196 | $55,218 | $161 |
| New patient visit (60+ min) | 191 | $37,528 | $196 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 126 | $5,648 | $30 |
| Return visit (30+ min) | 31 | $5,139 | $109 |
| Muscle electrical test | 16 | $2,475 | $103 |
2022: 5 services
| Long return visit (40+ min) | 179 | $44,279 | $170 |
| New patient visit (60+ min) | 171 | $33,239 | $194 |
| Return visit (30+ min) | 49 | $7,446 | $95 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 83 | $4,661 | $31 |
| Muscle electrical test | 15 | $1,914 | $101 |
2021: 5 services
| New patient visit (60+ min) | 210 | $42,541 | $203 |
| Long return visit (40+ min) | 167 | $38,394 | $163 |
| Return visit (30+ min) | 61 | $10,931 | $115 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 76 | $3,398 | $31 |
| Muscle electrical test | 17 | $2,378 | $103 |
2020: 9 services
| Return visit (30+ min) | 110 | $16,701 | $95 |
| New patient visit (60+ min) | 83 | $15,780 | $190 |
| Long return visit (40+ min) | 87 | $13,309 | $132 |
| New patient visit (45+ min) | 84 | $12,541 | $149 |
| Extended patient service without direct patient contact, first hour | 116 | $12,406 | $104 |
| Muscle electrical test | 24 | $3,511 | $100 |
| Short return visit (20+ min) | 17 | $1,358 | $71 |
| New patient visit (30+ min) | 12 | $1,051 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $858 | $72 |
2019: 6 services
| Long return visit (40+ min) | 127 | $24,319 | $129 |
| Return visit (30+ min) | 111 | $18,831 | $94 |
| New patient visit (60+ min) | 85 | $14,859 | $175 |
| New patient visit (45+ min) | 76 | $11,324 | $149 |
| Extended patient service without direct patient contact, first hour | 75 | $7,666 | $102 |
| Muscle electrical test | 22 | $3,672 | $97 |
2018: 5 services
| Long return visit (40+ min) | 116 | $21,344 | $132 |
| Return visit (30+ min) | 111 | $18,311 | $91 |
| New patient visit (60+ min) | 94 | $17,694 | $188 |
| New patient visit (45+ min) | 36 | $5,071 | $141 |
| Muscle electrical test | 17 | $2,292 | $92 |
2017: 6 services
| Return visit (30+ min) | 128 | $20,565 | $92 |
| Long return visit (40+ min) | 92 | $16,660 | $127 |
| New patient visit (60+ min) | 77 | $13,262 | $172 |
| New patient visit (45+ min) | 34 | $4,619 | $136 |
| Muscle electrical test | 37 | $4,612 | $90 |
| Nerve test | 17 | $2,429 | $143 |
2016: 6 services
| Return visit (30+ min) | 142 | $20,631 | $90 |
| Long return visit (40+ min) | 97 | $14,878 | $124 |
| New patient visit (60+ min) | 71 | $12,821 | $181 |
| New patient visit (45+ min) | 46 | $6,554 | $142 |
| Muscle electrical test | 30 | $3,820 | $89 |
| Nerve test | 16 | $2,130 | $133 |
2015: 7 services
| New patient visit (60+ min) | 119 | $23,032 | $194 |
| Long return visit (40+ min) | 116 | $20,400 | $128 |
| Return visit (30+ min) | 120 | $19,600 | $94 |
| Muscle electrical test | 45 | $6,601 | $94 |
| New patient visit (45+ min) | 43 | $5,976 | $139 |
| Nerve test | 23 | $3,352 | $146 |
| Nerve test | 13 | $2,577 | $198 |
2014: 8 services
| Long return visit (40+ min) | 117 | $20,472 | $121 |
| Return visit (30+ min) | 126 | $20,253 | $88 |
| New patient visit (60+ min) | 89 | $15,970 | $179 |
| New patient visit (45+ min) | 71 | $10,062 | $142 |
| Muscle electrical test | 64 | $7,872 | $88 |
| Nerve test | 26 | $3,051 | $117 |
| Nerve test | 12 | $2,591 | $216 |
| Nerve test | 20 | $2,231 | $112 |
2013: 8 services
| Return visit (30+ min) | 97 | $17,856 | $92 |
| New patient visit (60+ min) | 86 | $15,852 | $184 |
| Long return visit (40+ min) | 101 | $14,991 | $124 |
| New patient visit (45+ min) | 49 | $6,759 | $138 |
| Muscle electrical test | 59 | $6,005 | $82 |
| Nerve test | 24 | $3,059 | $127 |
| Nerve test | 23 | $2,475 | $108 |
| Nerve test | 12 | $1,956 | $163 |
Drugs they prescribed that Part D paid
$312,901
Pharmacies billed $312,901 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (14 of 845) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
725 generic and fewer than 11 brand-name prescriptions · $312,901 in drug cost · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Copaxone | None | 14 | $80,337 | $5,738 |
| Nuplazid | Parkinson's psychosis | 12 | $60,011 | $5,001 |
| Rytary | Parkinson's | 27 | $46,961 | $1,739 |
| Nurtec Odt | None | 13 | $33,874 | $2,606 |
| Emgality | Migraine | 13 | $9,864 | $759 |
See all 23 drugs
| Copaxone | None | 14 | $80,337 | $5,738 |
| Nuplazid | Parkinson's psychosis | 12 | $60,011 | $5,001 |
| Rytary | Parkinson's | 27 | $46,961 | $1,739 |
| Nurtec Odt | None | 13 | $33,874 | $2,606 |
| Emgality | Migraine | 13 | $9,864 | $759 |
| Ajovy | None | 12 | $8,430 | $703 |
| Carbidopa-Levodopa | None | 128 | $6,010 | $47 |
| Carbamazepine Er | None | 12 | $2,216 | $185 |
| Gabapentin | None | 66 | $2,057 | $31 |
| Levetiracetam | None | 40 | $1,928 | $48 |
| Memantine | None | 41 | $1,617 | $39 |
| Primidone | None | 24 | $1,482 | $62 |
| Oxcarbazepine | None | 15 | $1,447 | $96 |
| Levetiracetam Er | None | 20 | $1,391 | $70 |
| Propranolol Hcl Er | None | 28 | $958 | $34 |
| Donepezil | None | 75 | $871 | $12 |
| Propranolol | None | 24 | $683 | $28 |
| Pregabalin | None | 15 | $537 | $36 |
| Lamotrigine | None | 20 | $515 | $26 |
| Topiramate | None | 13 | $184 | $14 |
| Atorvastatin | None | 13 | $159 | $12 |
| Sumatriptan | None | 17 | $158 | $9 |
| Prednisone | None | 37 | $153 | $4 |
Year by year
| 2024 | 845 | 195 | 2% (14) | None | $312,901 |
| 2023 | 892 | 199 | 2% (13) | None | $300,292 |
| 2022 | 843 | 197 | 2% (16) | None | $111,162 |
| 2021 | 830 | 175 | 2% (17) | None | $117,820 |
| 2020 | 763 | 159 | 2% (12) | None | $215,615 |
| 2019 | 752 | 167 | None | None | $206,707 |
| 2018 | 695 | 150 | 2% (17) | 11% | $194,523 |
| 2017 | 623 | 140 | 2% (12) | None | $263,096 |
| 2016 | 588 | 139 | 3% (15) | None | $255,388 |
| 2015 | 619 | 143 | None | None | $204,261 |
| 2014 | 577 | 129 | 3% (17) | None | $155,556 |
| 2013 | 601 | 118 | None | None | $231,218 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Copaxone | None | 13 | $81,881 | $6,299 |
| Rytary | Parkinson's | 21 | $32,974 | $1,570 |
| Nurtec Odt | None | 15 | $31,224 | $2,082 |
| Carbidopa-Levodopa | None | 121 | $10,814 | $89 |
| Ajovy | None | 12 | $9,052 | $754 |
| Aimovig | Migraine | 11 | $8,679 | $789 |
| Emgality | Migraine | 12 | $8,361 | $697 |
| Memantine | None | 49 | $4,160 | $85 |
| Propranolol Hcl Er | None | 34 | $3,531 | $104 |
| Sumatriptan | None | 32 | $2,293 | $72 |
| Gabapentin | None | 67 | $2,226 | $33 |
| Levetiracetam | None | 37 | $1,838 | $50 |
| Propranolol | None | 30 | $1,714 | $57 |
| Pregabalin | None | 26 | $1,088 | $42 |
| Donepezil | None | 67 | $1,060 | $16 |
| Oxcarbazepine | None | 13 | $984 | $76 |
| Lamotrigine | None | 26 | $891 | $34 |
| Levetiracetam Er | None | 13 | $703 | $54 |
| Prednisone | None | 37 | $480 | $13 |
| Atorvastatin | None | 23 | $464 | $20 |
| Carbidopa-Levodopa Er | None | 11 | $393 | $36 |
| Primidone | None | 11 | $327 | $30 |
| Pramipexole Dihydrochloride | None | 18 | $98 | $5 |
2022: 24 drugs
| Carbidopa-Levodopa-Entacapone | 13 | $11,811 | $909 |
| Ajovy | 11 | $8,232 | $748 |
| Carbidopa-Levodopa | 117 | $7,334 | $63 |
| Dalfampridine Er | 19 | $5,899 | $310 |
| Gabapentin | 73 | $4,047 | $55 |
| Memantine | 44 | $3,966 | $90 |
| Propranolol Hcl Er | 31 | $3,348 | $108 |
| Levetiracetam | 41 | $1,943 | $47 |
| Sumatriptan | 62 | $1,542 | $25 |
| Pregabalin | 31 | $1,359 | $44 |
| Galantamine Er | 11 | $1,181 | $107 |
| Donepezil | 76 | $1,180 | $16 |
| Propranolol | 17 | $933 | $55 |
| Levetiracetam Er | 14 | $916 | $65 |
| Primidone | 14 | $901 | $64 |
| Lamotrigine | 19 | $789 | $42 |
| Pramipexole Dihydrochloride | 22 | $671 | $31 |
| Carbidopa-Levodopa Er | 14 | $564 | $40 |
| Amitriptyline | 12 | $555 | $46 |
| Oxcarbazepine | 12 | $427 | $36 |
| Topiramate | 17 | $269 | $16 |
| Hydrocodone-Acetaminophen | 11 | $190 | $17 |
| Atorvastatin | 15 | $161 | $11 |
| Prednisone | 11 | $87 | $8 |
2021: 23 drugs
| Carbidopa-Levodopa-Entacapone | 15 | $10,964 | $731 |
| Rasagiline Mesylate | 11 | $9,233 | $839 |
| Carbidopa-Levodopa | 120 | $8,647 | $72 |
| Levetiracetam | 60 | $3,478 | $58 |
| Memantine | 39 | $3,205 | $82 |
| Carbamazepine Er | 16 | $2,835 | $177 |
| Dalfampridine Er | 16 | $2,327 | $145 |
| Propranolol Hcl Er | 19 | $2,074 | $109 |
| Gabapentin | 50 | $1,757 | $35 |
| Pregabalin | 21 | $1,507 | $72 |
| Carbidopa-Levodopa Er | 21 | $1,389 | $66 |
| Donepezil | 77 | $1,338 | $17 |
| Levetiracetam Er | 15 | $1,324 | $88 |
| Sumatriptan | 50 | $1,036 | $21 |
| Amitriptyline | 21 | $1,005 | $48 |
| Pramipexole Dihydrochloride | 26 | $976 | $38 |
| Ropinirole | 18 | $949 | $53 |
| Primidone | 12 | $931 | $78 |
| Lamotrigine | 22 | $877 | $40 |
| Galantamine Er | 12 | $692 | $58 |
| Topiramate | 18 | $474 | $26 |
| Hydrocodone-Acetaminophen | 11 | $180 | $16 |
| Prednisone | 12 | $96 | $8 |
2020: 23 drugs
| Carbidopa-Levodopa-Entacapone | 17 | $14,142 | $832 |
| Rasagiline Mesylate | 13 | $11,013 | $847 |
| Carbidopa-Levodopa | 104 | $6,382 | $61 |
| Pregabalin | 20 | $4,512 | $226 |
| Memantine | 41 | $3,159 | $77 |
| Carbamazepine Er | 15 | $3,097 | $206 |
| Levetiracetam | 71 | $2,953 | $42 |
| Pramipexole Dihydrochloride | 31 | $2,384 | $77 |
| Propranolol Hcl Er | 24 | $1,881 | $78 |
| Primidone | 20 | $1,402 | $70 |
| Gabapentin | 33 | $1,355 | $41 |
| Oxcarbazepine | 12 | $1,075 | $90 |
| Ropinirole | 17 | $1,026 | $60 |
| Levetiracetam Er | 11 | $947 | $86 |
| Propranolol | 13 | $912 | $70 |
| Donepezil | 49 | $809 | $17 |
| Amitriptyline | 17 | $776 | $46 |
| Sumatriptan | 37 | $723 | $20 |
| Carbidopa-Levodopa Er | 13 | $644 | $50 |
| Lamotrigine | 13 | $507 | $39 |
| Topiramate | 15 | $327 | $22 |
| Prednisone | 15 | $295 | $20 |
| Atorvastatin | 15 | $155 | $10 |
2019: 20 drugs
| Carbidopa-Levodopa-Entacapone | 12 | $11,047 | $921 |
| Carbidopa-Levodopa | 88 | $5,255 | $60 |
| Memantine | 54 | $2,926 | $54 |
| Divalproex Sodium Er | 19 | $2,909 | $153 |
| Carbamazepine Er | 11 | $2,819 | $256 |
| Gabapentin | 51 | $2,389 | $47 |
| Levetiracetam | 70 | $2,033 | $29 |
| Sumatriptan | 20 | $2,006 | $100 |
| Primidone | 32 | $1,597 | $50 |
| Pramipexole Dihydrochloride | 22 | $1,430 | $65 |
| Ropinirole | 18 | $1,379 | $77 |
| Propranolol Hcl Er | 17 | $1,368 | $80 |
| Carbidopa-Levodopa Er | 22 | $1,266 | $58 |
| Levetiracetam Er | 13 | $1,048 | $81 |
| Donepezil | 39 | $953 | $24 |
| Propranolol | 11 | $732 | $67 |
| Lamotrigine | 21 | $649 | $31 |
| Atorvastatin | 22 | $418 | $19 |
| Prednisone | 17 | $254 | $15 |
| Topiramate | 15 | $83 | $6 |
2018: 21 drugs
| Carbidopa-Levodopa-Entacapone | 13 | $9,854 | $758 |
| Memantine Hcl Er | 12 | $8,707 | $726 |
| Divalproex Sodium Er | 17 | $5,552 | $327 |
| Carbidopa-Levodopa | 78 | $5,139 | $66 |
| Memantine | 47 | $3,443 | $73 |
| Carbamazepine Er | 20 | $3,442 | $172 |
| Levetiracetam | 52 | $1,789 | $34 |
| Gabapentin | 44 | $1,553 | $35 |
| Propranolol | 17 | $1,358 | $80 |
| Sumatriptan | 30 | $1,207 | $40 |
| Carbidopa-Levodopa Er | 27 | $1,159 | $43 |
| Propranolol Hcl Er | 12 | $1,069 | $89 |
| Ropinirole | 13 | $916 | $70 |
| Donepezil | 44 | $892 | $20 |
| Levetiracetam Er | 15 | $832 | $55 |
| Pramipexole Dihydrochloride | 16 | $447 | $28 |
| Clopidogrel | 13 | $397 | $31 |
| Lamotrigine | 13 | $308 | $24 |
| Atorvastatin | 11 | $199 | $18 |
| Prednisone | 25 | $142 | $6 |
| Topiramate | 12 | $61 | $5 |
2017: 17 drugs
| Namenda Xr | 22 | $18,169 | $826 |
| Rivastigmine | 13 | $10,995 | $846 |
| Lyrica | 11 | $8,221 | $747 |
| Carbidopa-Levodopa-Entacapone | 13 | $6,908 | $531 |
| Carbidopa-Levodopa | 77 | $4,059 | $53 |
| Memantine | 31 | $3,235 | $104 |
| Carbamazepine Er | 14 | $2,107 | $151 |
| Gabapentin | 58 | $1,752 | $30 |
| Levetiracetam | 35 | $1,221 | $35 |
| Pramipexole Dihydrochloride | 15 | $955 | $64 |
| Propranolol | 18 | $890 | $49 |
| Ropinirole | 14 | $822 | $59 |
| Donepezil | 37 | $811 | $22 |
| Sumatriptan | 21 | $782 | $37 |
| Carbidopa-Levodopa Er | 15 | $589 | $39 |
| Citalopram Hbr | 13 | $194 | $15 |
| Prednisone | 14 | $100 | $7 |
2016: 15 drugs
| Namenda Xr | 48 | $31,842 | $663 |
| Lyrica | 11 | $7,804 | $709 |
| Memantine | 26 | $2,943 | $113 |
| Carbidopa-Levodopa | 52 | $2,498 | $48 |
| Gabapentin | 46 | $1,631 | $35 |
| Levetiracetam | 29 | $1,317 | $45 |
| Donepezil | 50 | $874 | $17 |
| Carbidopa-Levodopa Er | 19 | $818 | $43 |
| Propranolol | 11 | $801 | $73 |
| Hydrocodone-Acetaminophen | 13 | $529 | $41 |
| Lamotrigine | 13 | $425 | $33 |
| Topiramate | 15 | $243 | $16 |
| Sertraline | 12 | $144 | $12 |
| Citalopram Hbr | 11 | $101 | $9 |
| Prednisone | 16 | $93 | $6 |
2015: 15 drugs
| Namenda | 34 | $19,490 | $573 |
| Namenda Xr | 17 | $12,943 | $761 |
| Carbidopa-Levodopa | 86 | $4,211 | $49 |
| Memantine | 11 | $1,975 | $180 |
| Gabapentin | 50 | $1,459 | $29 |
| Levetiracetam | 29 | $1,442 | $50 |
| Pramipexole Dihydrochloride | 20 | $1,342 | $67 |
| Sumatriptan | 12 | $1,163 | $97 |
| Donepezil | 60 | $1,125 | $19 |
| Carbidopa-Levodopa Er | 17 | $1,099 | $65 |
| Levetiracetam Er | 11 | $982 | $89 |
| Primidone | 11 | $866 | $79 |
| Lamotrigine | 20 | $567 | $28 |
| Topiramate | 17 | $257 | $15 |
| Prednisone | 20 | $185 | $9 |
2014: 15 drugs
| Namenda | 38 | $27,565 | $725 |
| Azilect | 18 | $14,363 | $798 |
| Neupro | 11 | $6,486 | $590 |
| Carbidopa-Levodopa | 86 | $4,425 | $51 |
| Levetiracetam | 31 | $2,129 | $69 |
| Ropinirole | 13 | $1,440 | $111 |
| Donepezil | 55 | $1,360 | $25 |
| Pramipexole Dihydrochloride | 22 | $1,174 | $53 |
| Gabapentin | 28 | $885 | $32 |
| Primidone | 17 | $768 | $45 |
| Lamotrigine | 18 | $593 | $33 |
| Topiramate | 18 | $540 | $30 |
| Hydrocodone-Acetaminophen | 12 | $296 | $25 |
| Citalopram Hbr | 12 | $186 | $15 |
| Prednisone | 14 | $143 | $10 |
2013: 19 drugs
| Copaxone | 13 | $80,513 | $6,193 |
| Namenda | 45 | $25,577 | $568 |
| Azilect | 18 | $13,057 | $725 |
| Exelon | 24 | $11,100 | $463 |
| Neupro | 11 | $6,466 | $588 |
| Levetiracetam | 44 | $4,583 | $104 |
| Galantamine Hbr | 16 | $3,593 | $225 |
| Carbidopa-Levodopa | 70 | $3,387 | $48 |
| Donepezil | 56 | $2,051 | $37 |
| Gabapentin | 41 | $1,596 | $39 |
| Propranolol | 15 | $1,520 | $101 |
| Primidone | 15 | $1,489 | $99 |
| Ropinirole | 11 | $1,031 | $94 |
| Lamotrigine | 20 | $963 | $48 |
| Pramipexole Dihydrochloride | 13 | $688 | $53 |
| Clopidogrel | 15 | $573 | $38 |
| Topiramate | 14 | $561 | $40 |
| Sumatriptan | 13 | $550 | $42 |
| Prednisone | 19 | $87 | $5 |
Money from drug and device companies
$3,350 in 2025
| 2025 | 21 | 142 | None | $3,350 |
| 2024 | 20 | 114 | None | $2,814 |
| 2023 | 10 | 65 | None | $1,285 |
| 2022 | 8 | 21 | None | $444 |
| 2021 | 17 | 41 | $26 | $781 |
| 2020 | 12 | 38 | None | $632 |
| 2019 | 11 | 53 | $23 | $1,176 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $667 | 30 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $387 | 13 payments
|
| SK Life Science | None | $310 | 21 payments
|
| Novartis Pharmaceuticals | Kesimpta | $277 | 7 payments
|
| Neurelis | Valtoco | $247 | 9 payments
|
| Pfizer | Nurtec Odt | $241 | 16 payments
|
See all 142 published payments
| SK Life Science | Meals · 2025-12-24 | None | $8 |
| Neurocrine BioSciences | Meals · 2025-12-20 | Ingrezza | $37 |
| Neurelis | Meals · 2025-12-18 | Valtoco | $29 |
| Axsome Therapeutics | Meals · 2025-12-17 | Symbravo | $15 |
| Amgen | Meals · 2025-12-16 | Uplizna | $33 |
| Pfizer | Meals · 2025-12-16 | Nurtec Odt | $12 |
| Merz Pharmaceuticals | Meals · 2025-12-15 | Inbrija | $23 |
| Abbvie | Meals · 2025-12-10 | Botox | $24 |
| Novartis Pharmaceuticals | Meals · 2025-12-09 | Kesimpta | $11 |
| Ucb | Meals · 2025-12-09 | Rystiggo | $25 |
| CSL Behring | Meals · 2025-12-03 | Hizentra | $22 |
| Amgen | Meals · 2025-11-24 | Uplizna | $21 |
| SK Life Science | Meals · 2025-11-19 | None | $28 |
| Abbvie | Meals · 2025-11-18 | Qulipta | $11 |
| Alexion Pharmaceuticals | Meals · 2025-11-18 | None | $132 |
| Neurelis | Meals · 2025-11-18 | Valtoco | $36 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Kesimpta | $19 |
| Pfizer | Meals · 2025-11-12 | Aromasin | $18 |
| Pfizer | Meals · 2025-11-04 | Nurtec Odt | $14 |
| Teva Pharmaceuticals USA | Education · 2025-11-04 | None | $111 |
| Teva Pharmaceuticals USA | Meals · 2025-11-04 | Austedo Xr | $36 |
| Amgen | Meals · 2025-10-31 | Uplizna | $45 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Kesimpta | $14 |
| Lundbeck | Meals · 2025-10-25 | Rexulti | $30 |
| Abbvie | Meals · 2025-10-24 | Botox | $28 |
| Abbvie | Meals · 2025-10-22 | Qulipta | $11 |
| Genentech USA | Meals · 2025-10-21 | Ocrevus Zunovo | $19 |
| Pfizer | Meals · 2025-10-17 | Nurtec Odt | $10 |
| SK Life Science | Meals · 2025-10-16 | None | $13 |
| Neurocrine BioSciences | Meals · 2025-10-15 | Ingrezza | $39 |
| Pfizer | Meals · 2025-10-10 | Nurtec Odt | $17 |
| SK Life Science | Meals · 2025-10-08 | None | $22 |
| Teva Pharmaceuticals USA | Meals · 2025-10-07 | Ajovy | $21 |
| Merz Pharmaceuticals | Meals · 2025-10-06 | Xeomin | $26 |
| Abbvie | Meals · 2025-10-02 | Qulipta | $21 |
| Amgen | Meals · 2025-09-26 | Uplizna | $23 |
| Ucb | Meals · 2025-09-19 | Rystiggo | $34 |
| Pfizer | Meals · 2025-09-16 | Nurtec Odt | $17 |
| MDD US Operations | Meals · 2025-09-16 | None | $16 |
| SK Life Science | Meals · 2025-09-16 | None | $14 |
| Teva Pharmaceuticals USA | Meals · 2025-09-11 | Austedo Xr | $38 |
| SK Life Science | Meals · 2025-09-03 | None | $12 |
| Neurelis | Meals · 2025-09-02 | Valtoco | $22 |
| Pfizer | Meals · 2025-08-29 | Nurtec Odt | $18 |
| Biogen | Meals · 2025-08-28 | Tysabri | $21 |
| Neurocrine BioSciences | Meals · 2025-08-27 | Ingrezza | $36 |
| SK Life Science | Meals · 2025-08-27 | None | $18 |
| Novartis Pharmaceuticals | Meals · 2025-08-21 | Kesimpta | $19 |
| Ucb | Meals · 2025-08-21 | Rystiggo | $31 |
| Lundbeck | Meals · 2025-08-21 | Rexulti | $35 |
| SK Life Science | Meals · 2025-08-19 | None | $13 |
| Abbvie | Meals · 2025-08-14 | Qulipta | $14 |
| Abbvie | Meals · 2025-08-13 | Qulipta | $9 |
| Neurelis | Meals · 2025-08-13 | Valtoco | $41 |
| Pfizer | Meals · 2025-08-12 | Nurtec Odt | $10 |
| Pfizer | Meals · 2025-08-07 | Nurtec Odt | $15 |
| Abbvie | Meals · 2025-08-06 | Botox | $30 |
| SK Life Science | Meals · 2025-08-04 | None | $14 |
| Abbvie | Meals · 2025-07-23 | Botox | $20 |
| Ucb | Meals · 2025-07-17 | Rystiggo | $23 |
| Neurelis | Meals · 2025-07-16 | Valtoco | $39 |
| Neurocrine BioSciences | Meals · 2025-07-16 | Ingrezza | $13 |
| Pfizer | Meals · 2025-07-14 | Nurtec Odt | $11 |
| Ucb | Meals · 2025-07-11 | Rystiggo | $17 |
| Biogen | Meals · 2025-07-10 | Vumerity | $28 |
| Ucb | Meals · 2025-07-10 | Rystiggo | $4 |
| SK Life Science | Meals · 2025-07-08 | None | $1 |
| SK Life Science | Meals · 2025-07-08 | None | $12 |
| Teva Pharmaceuticals USA | Meals · 2025-07-02 | Austedo Xr | $25 |
| TG Therapeutics | Meals · 2025-06-26 | Briumvi | $33 |
| Pfizer | Meals · 2025-06-25 | Nurtec Odt | $9 |
| SK Life Science | Meals · 2025-06-24 | None | $13 |
| MDD US Operations | Meals · 2025-06-19 | None | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-06-16 | Austedo Xr | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-06-16 | Austedo Xr | $12 |
| Neurelis | Meals · 2025-06-11 | Valtoco | $33 |
| SK Life Science | Meals · 2025-06-11 | None | $15 |
| Alexion Pharmaceuticals | Meals · 2025-06-07 | Ultomiris | $10 |
| Teva Pharmaceuticals USA | Meals · 2025-05-27 | Austedo Xr | $20 |
| SK Life Science | Meals · 2025-05-27 | None | $11 |
| Neurelis | Meals · 2025-05-21 | Valtoco | $25 |
| Abbvie | Meals · 2025-05-14 | Botox | $19 |
| Abbvie | Meals · 2025-05-10 | Ubrelvy | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-05-08 | Austedo Xr | $43 |
| SK Life Science | Meals · 2025-05-08 | None | $12 |
| Amneal Pharmaceuticals | Meals · 2025-05-06 | Rytary | $28 |
| Ucb | Meals · 2025-05-01 | Rystiggo | $1 |
| Ucb | Meals · 2025-05-01 | Rystiggo | $11 |
| Pfizer | Meals · 2025-04-30 | Nurtec Odt | $26 |
| Neurocrine BioSciences | Meals · 2025-04-30 | Ingrezza | $35 |
| Abbvie | Meals · 2025-04-28 | Botox | $11 |
| Abbvie | Meals · 2025-04-26 | Ubrelvy | $35 |
| TG Therapeutics | Meals · 2025-04-22 | Briumvi | $21 |
| Pfizer | Meals · 2025-04-22 | Nurtec Odt | $9 |
| Lundbeck | Meals · 2025-04-17 | Rexulti | $27 |
| SK Life Science | Meals · 2025-04-16 | None | $12 |
| SK Life Science | Meals · 2025-04-11 | None | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-09 | Wainua | $21 |
| Abbvie | Meals · 2025-04-08 | Ubrelvy | $29 |
| Novartis Pharmaceuticals | Meals · 2025-04-07 | Kesimpta | $61 |
| Novartis Pharmaceuticals | Meals · 2025-04-06 | Kesimpta | $132 |
| Abbvie | Meals · 2025-04-04 | Botox | $30 |
| Abbvie | Meals · 2025-03-28 | Botox | $32 |
| Ucb | Meals · 2025-03-28 | Zilbrysq | $10 |
| Ucb | Meals · 2025-03-28 | Zilbrysq | $14 |
| Otsuka America Pharmaceutical | Meals · 2025-03-26 | Rexulti | $21 |
| Abbvie | Meals · 2025-03-25 | Ubrelvy | $29 |
| Abbvie | Meals · 2025-03-20 | Ubrelvy | $16 |
| Amneal Pharmaceuticals | Meals · 2025-03-19 | Rytary | $19 |
| Biogen | Meals · 2025-03-18 | Vumerity | $26 |
| Pfizer | Meals · 2025-03-14 | Nurtec Odt | $22 |
| Abbvie | Meals · 2025-03-13 | Botox | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-03-13 | Ajovy | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-03-13 | Austedo Xr | $30 |
| SK Life Science | Meals · 2025-03-12 | None | $32 |
| Abbvie | Meals · 2025-03-08 | Ubrelvy | $31 |
| Novartis Pharmaceuticals | Meals · 2025-03-04 | Kesimpta | $21 |
| Abbvie | Meals · 2025-03-04 | Qulipta | $17 |
| Amneal Pharmaceuticals | Meals · 2025-02-28 | Rytary | $14 |
| Abbvie | Meals · 2025-02-27 | Ubrelvy | $30 |
| TG Therapeutics | Meals · 2025-02-27 | Briumvi | $42 |
| Neurocrine BioSciences | Meals · 2025-02-26 | Ingrezza | $36 |
| Neurelis | Meals · 2025-02-25 | Valtoco | $10 |
| Neurelis | Meals · 2025-02-25 | Valtoco | $13 |
| Pfizer | Meals · 2025-02-24 | Nurtec Odt | $24 |
| SK Life Science | Meals · 2025-02-21 | None | $17 |
| Abbvie | Meals · 2025-02-20 | Botox | $35 |
| Teva Pharmaceuticals USA | Meals · 2025-02-20 | Austedo Xr | $28 |
| Abbvie | Meals · 2025-02-19 | Ubrelvy | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-02-11 | Rexulti | $25 |
| Abbvie | Meals · 2025-02-06 | Qulipta | $30 |
| Biogen | Meals · 2025-02-06 | Vumerity | $24 |
| Abbvie | Meals · 2025-01-30 | Ubrelvy | $27 |
| SK Life Science | Meals · 2025-01-30 | None | $11 |
| Neurocrine BioSciences | Meals · 2025-01-29 | Ingrezza | $36 |
| Abbvie | Meals · 2025-01-24 | Qulipta | $16 |
| Abbvie | Meals · 2025-01-17 | Botox | $9 |
| Abbvie | Meals · 2025-01-15 | Botox | $16 |
| Abbvie | Meals · 2025-01-15 | Ubrelvy | $23 |
| Teva Pharmaceuticals USA | Meals · 2025-01-15 | Austedo Xr | $14 |
| SK Life Science | Meals · 2025-01-14 | None | $12 |
| Pfizer | Meals · 2025-01-09 | Nurtec Odt | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,814
| Abbvie | Ubrelvy | $898 | 40 payments
|
| SK Life Science | Xcopri | $313 | 18 payments
|
| MDD US Operations | Gocovri | $301 | 11 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $291 | 12 payments
|
| Neurocrine Biosciences | Ingrezza | $194 | 6 payments
|
| Amgen | Uplizna | $160 | 3 payments
|
| Eisai | Leqembi | $125 | 1 payment
|
| Ucb | Rystiggo | $96 | 3 payments
|
| Novartis Pharmaceuticals | Kesimpta | $87 | 4 payments
|
| Lilly USA | Emgality | $65 | 3 payments
|
| Sumitomo Pharma America | Aptiom | $52 | 2 payments
|
| Acorda Therapeutics | Inbrija | $48 | 2 payments
|
| Lundbeck | Vyepti | $32 | 1 payment
|
| Pfizer | Nurtec Odt | $28 | 2 payments
|
| Banner Life Sciences | Bafiertam | $25 | 1 payment
|
| Biogen | Tysabri | $23 | 1 payment
|
| Amneal Pharmaceuticals | Unithroid | $22 | 1 payment
|
| Kyowa Kirin | Nourianz | $20 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $20 | 1 payment
|
| Averitas Pharma | Qutenza | $15 | 1 payment
|
2023: $1,285
| Abbvie | Qulipta | $510 | 26 payments
|
| Impel Pharmaceuticals | Trudhesa | $272 | 21 payments
|
| Pfizer | Zavzpret | $159 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $86 | 3 payments
|
| Alexion Pharmaceuticals | None | $60 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $53 | 2 payments
|
| Genentech USA | Enspryng | $49 | 2 payments
|
| MDD US Operations | None | $42 | 2 payments
|
| SK Life Science | None | $30 | 1 payment
|
| Lilly USA | Emgality | $23 | 1 payment
|
2022: $444
| Abbvie | Botox | $211 | 8 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $98 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo | $48 | 2 payments
|
| Horizon Therapeutics plc | Uplizna | $21 | 1 payment
|
| SK Life Science | None | $19 | 1 payment
|
| Ucb | Briviact | $19 | 1 payment
|
| Lilly USA | Emgality | $15 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $12 | 1 payment
|
2021: $781
| AbbVie | Ubrelvy | $132 | 11 payments
|
| Biogen | Tysabri | $86 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $85 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $84 | 4 payments
|
| Kyowa Kirin | Nourianz | $69 | 4 payments
|
| Alexion Pharmaceuticals | Soliris | $49 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $45 | 2 payments
|
| Adamas Pharmaceuticals | Gocovri | $31 | 1 payment
|
| Allergan | Botox | $30 | 1 payment
|
| Acorda Therapeutics | Inbrija | $26 | 1 payment
|
| SK Life Science | Xcopri | $25 | 1 payment
|
| Lilly USA | Emgality | $23 | 1 payment
|
| Lundbeck | Vyepti | $22 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $21 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $20 | 1 payment
|
| Ucb | Briviact | $20 | 1 payment
|
| CSL Behring | Hizentra | $13 | 1 payment
|
2020: $632
| EMD Serono | Mavenclad | $181 | 16 payments
|
| Avanir Pharmaceuticals | Nuedexta | $80 | 4 payments
|
| Alexion Pharmaceuticals | Soliris | $79 | 4 payments
|
| Ucb | Briviact | $63 | 2 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $56 | 2 payments
|
| Allergan | Ubrelvy | $46 | 2 payments
|
| Novartis Pharmaceuticals | Gilenya | $35 | 2 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $29 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $18 | 1 payment
|
| Adamas Pharmaceuticals | Gocovri | $17 | 1 payment
|
| Kyowa Kirin | Nourianz | $16 | 1 payment
|
| Lilly USA | Emgality | $12 | 1 payment
|
2019: $1,176
| Novartis Pharmaceuticals | Mayzent | $382 | 7 payments
|
| EMD Serono | Mavenclad | $233 | 27 payments
|
| Ucb | Neupro | $133 | 5 payments
|
| Alexion Pharmaceuticals | Soliris | $125 | 4 payments
|
| Boston Scientific | Watchman | $121 | 1 payment
|
| Amgen | Aimovig | $55 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $44 | 2 payments
|
| Eisai | Fycompa | $33 | 2 payments
|
| Acorda Therapeutics | Inbrija | $23 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $15 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $13 | 1 payment
|
Professional record
- NPI
- 1033226758
- Licence
- CA A74994California A74994: Current · expires 2027-03-31
- Trained
- Yale University School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-08-25
- NPI last updated
- 2020-05-20
- NPI record certified
- 2020-05-20
This is when the NPI record was last certified, not a medical board exam.